Mustang Bio, Inc. Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of MBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending March 31, 2022 was 40.2% (a -957.14% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth increased by 479.25%
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 17.77% (a -41.26% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was 30.25% (a -37.55% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2019 was 48.44% (a 141.48% increase from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending March 31, 2022 was 22.33% (a 25.66% increase compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth increased by 25.87% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
22.33% 17.77% 32.04% 17.74%
Visit stockrow.com/MBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Mustang Bio, Inc.

Most recent Research and Development (R&D) Expenses Growthof MBIO including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Mustang Bio, Inc.

Mustang Bio, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 40.2%
2021 -4.69% 77.82% 6.94% 21.48% 17.77%
2020 32.15% 3.31% 58.48% 29.07% 30.25%
2019 35.69% 26.8% 97.44% 69.68% 48.44%
2018 -18.94% 153.86% -10.94% 240.91% 20.06%
2017 84.7% 337.26% 586.25% 125.93% 138.4%
2016 1098.07% -77.13% -85.43% -55.74% 0.0%
2015 -91.65% -100.0%

Business Profile of Mustang Bio, Inc.

Sector: Healthcare
Industry: Biotechnology